Regulatory 6 June 2024 Telix heads to the US, as RayzeBio runs into problems Supply continues to cause headaches for radiopharmaceutical developers. Read more
Conferences Trial results 19 January 2024 ASCO-GI – Novartis looks for earlier Lutathera use Read more